TITLE

Increased Frequency of Autoimmune Diseases in Patients With Primary Sclerosing Cholangitis

AUTHOR(S)
Saarinen, S.; Olerup, O.; Broomé, U.
PUB. DATE
November 2000
SOURCE
American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3195
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown origin that mostly affects male patients with inflammatory bowel disease (IBD). The immune system is believed to be involved in the etiology/pathogenesis as these patients present with several immunological disturbances. Susceptibility to develop primary sclerosing cholangitis is partly determined by genes in the HLA complex. The aim of this study was to compare the prevalence of autoimmune disorders in IBD patients with and without PSC and to correlate the presence of autoimmune disorders in PSC to outcome and HLA association. METHODS: One hundred nineteen PSC patients were included in the study. Each PSC patient with IBD was matched to a IBD patient without PSC. The presence of autoimmune disorders was carefully evaluated in each group. Moreover, comparisons between PSC patients with and without autoimmune disorders were performed. RESULTS: Twenty-five percent of the PSC patients had at least one autoimmune disorder outside the liver and colon compared to 9% in the IBD group without PSC (p < 0.005). Nine of the PSC patients had two or more autoimmune diseases compared to only one patient in the IBD group (p < 0.02). The PSC patients with and without associated autoimmune disease did not differ in clinical presentation, outcome of PSC or HLA alleles. A significant overrepresentation of DRB 1*03 was still present after excluding PSC patients with concomitant autoimmune diseases outside the liver and colon compared to a healthy Swedish control group. CONCLUSIONS: Autoimmune disorders are more frequent among PSC patients compared to IBD patients without liver disease. Associated autoimmune diseases in PSC patients does not influence the outcome or clinical presentation of PSC.
ACCESSION #
17628592

 

Related Articles

  • Early Nodular Hyperplasia of the Liver Occurring With Inflammatory Bowel Diseases in Association With Thioguanine Therapy. Shastri, Sunita; Dubinsky, Marla C.; Poordad, F. Fred; Vasiliauskas, Eric A.; Geller, Stephen A. // Archives of Pathology & Laboratory Medicine;Jan2004, Vol. 128 Issue 1, p49 

    Context.--Nodular hyperplasia (also referred to as nodular regenerative hyperplasia and nodular regenerative hyperplasia of the liver) is a sequel to therapy with thioguanine in patients with hematologic malignancies. Recently, 6-thioguanine has been used to treat patients with inflammatory...

  • A Clinician's Primer on the Role of the Microbiome in Human Health and Disease. Khanna, Sahil; Tosh, Pritish K. // Mayo Clinic Proceedings;Jan2014, Vol. 89 Issue 1, p107 

    The importance of the commensal microbiota that colonizes the skin, gut, and mucosal surfaces of the human body is being increasingly recognized through a rapidly expanding body of science studying the human microbiome. Although, at first glance, these discoveries may seem esoteric, the clinical...

  • Simultaneous Occurrence of Inflammatory Bowel Disease and Thyroid Disease. Bonapace, Eugene S.; Srinivasan, Radhika // American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1925 

    We report a case of simultaneous occurrence of inflammatory bowel disease (IBD) and Graves' disease. A review of reported cases of simultaneous onset of ulcerative colitis (UC) and autoimmune hyperthyroidism is presented. A discussion of the prevalence of thyroid disease in patients with UC and...

  • Oral Tolerance Therapy in Inflammatory Bowel Disease. Jae Geun Hyun; Barrett, Terrence A. // American Journal of Gastroenterology;Mar2006, Vol. 101 Issue 3, p569 

    Oral tolerance is a long-recognized method of inducing immune tolerance or systemic hyporesponsiveness induced by feeding protein. Oral tolerance has been used to prevent and/or treat a variety of T-cell-mediated autoimmune disorders. Feeding colonic extracts prevented colitis in animal model of...

  • Patterns of Biologic Agent Use in Older Males with Inflammatory Diseases: An Institution-Focused, Observational Post-Marketing Study. Suong Tran; Hooker, Roderick S.; Cipher, Daisha J.; Reimold, Andreas // Drugs & Aging;2009, Vol. 26 Issue 7, p607 

    Background: Little investigation has focused on use of biologic agents in elderly patients with rheumatoid arthritis, spondyloarthropathies, inflammatory bowel disease or psoriasis. Furthermore, studies of drugs for autoimmune diseases that do include elderly populations have tended to include a...

  • Inflammatory bowel disease requires the interplay between innate and adaptive immune signals. Shi, Dayna; Das, Jyoti; Das, Gobardhan // Cell Research;Jan2006, Vol. 16 Issue 1, p70 

    Inflammatory bowl disease (IBD) is a type 1 T helper cell (Th1)-mediated autoimmune disease. Various studies have revealed that environmental pathogens also play a significant role in the initiation and progression of this disease. Interestingly, the pathogenesis of IBD has been shown to be...

  • Journal Scan.  // Gut;Dec2003, Vol. 52 Issue 12, p1796 

    The article presents glimpses of several articles that are published in different journals. The article "Impact of Liver Biopsy Size on Histological Education of chronic Viral Hepatitis: The Smaller the Sample, the Milder the Disease," describes that live

  • The Effect of Gender on the Rates of Hospitalization for Gastrointestinal Illnesses. Zarling, Edwin J.; Bernsen, Mitchell B. // American Journal of Gastroenterology;Apr1997, Vol. 92 Issue 4, p621 

    Objectives: Over the years, reports have indicated that many medical illnesses show a predilection for one of the genders. Such observations are important, in part, because they may provide insights into the pathophysiology of the illness. Unfortunately, these observations often have been based...

  • Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature. Larsen, Erling Peter; Bayat, Allan; Vyberg, Mogens // Diagnostic Pathology;2012, Vol. 7 Issue 1, p100 

    Abstract: Autoimmune sclerosing cholangitis is an overlap syndrome characterized by features of both autoimmune hepatitis and primary sclerosing cholangitis, the latter usually involving the large bile ducts. Autoimmune sclerosing cholangitis occurs more often in children than in adults and is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics